期刊文献+

瘦素与骨代谢研究进展 被引量:5

Recent progress of leptin and bone metabolism
原文传递
导出
摘要 瘦素是主要在脂肪组织中表达的脂肪因子,其作用有多效性,近来研究显示瘦素对骨代谢的调节也发挥重要作用。临床试验中关于瘦素与骨密度之间的相关性目前尚未得出一致结论。瘦素可以通过中枢作用、交感神经系统、外周作用等途径调节骨代谢。其中血清素、神经介素U、神经肽Y是瘦素通过中枢作用调节骨代谢的重要介质。另外,瘦素对骨代谢的效应与其血浆水平相关。瘦素对骨代谢的调节可能为骨质疏松的治疗提供新的方向。 Leptin, an adipokine deriving mainly from adipose tissue, demonstrates pleiotropic effects. Recent studies show that it emerges as a significant factor in the regulation of bone metabolism. However, it is still controvesial of the relationship between leptin and bone mineral density (BMD)in clinical trials. Leptin can regulate bone metabolism by central pathways, peripheral pathways and sympathetic nervous system. In central pathways, serotonin, neuromedin U and neuropeptide Y are key mediators in the regulation of leptin on bone metabolism. In additon, the overall effect of leptin on bone metabolism might depend on serum leptin concentrations. The regulation of leptin on bone metabolism may provide a new direction for the treatment of osteoporosis.
出处 《国际内分泌代谢杂志》 北大核心 2012年第3期200-202,共3页 International Journal of Endocrinology and Metabolism
关键词 瘦素 骨代谢 血清素 交感神经系统 Leptin Bone metabolism Serotonin Sympathetic nervous system
  • 相关文献

参考文献22

  • 1彭绍蓉.不同人群的瘦素水平在骨质疏松中作用的研究.中华医学会第六次全国骨质疏松和骨矿盐疾病学术会议论文汇编.苏州,2011.
  • 2Rhie YJ, Lee KH, Chung SC, et al. Effects of body composition, leptin, and adiponectin on bone mineral density in prepubertal girls. J Korean Med Sci ,2010,25 : 1187-1190.
  • 3Koroglu BK, Kiris F, Ersoy IH, et al. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynol Pol,2011,62 :429-435.
  • 4Iida T, Domoto T,Takigawa A,et al. Relationships among blood leptin and adiponeetin levels, fat mass, and bone mineral density in Japanese preand postmenopausal women. Hiroshima J Med Sci ,2011,60:71-78.
  • 5Yadav VK, Karsenty G. Leptin-dependent co-regulation of bone and energy metabolism. Aging (Albany NY) ,2009,1 : 954-956.
  • 6Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell, 2008, 135 : 825-837.
  • 7Richards JB, Papaioannou A, Adachi JD, et al. Effect of slective srotonin ruptake ihibitors on the risk of fracture. Arch Intern Med, 2007,167 : 188-194.
  • 8Yadav VK,Oury F, Suda N,et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell ,2009,138:976-989.
  • 9Sato S, Hanada R, Kimura A, et al. Central control of bone remodeling by neuromedin U. Nat Med,2007 ,13 :1234-1240.
  • 10Baldock PA,Lee N J, Driessler F,et al. Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One,2009,4 : e8415.

同被引文献37

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部